FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
HEXALEN
altretamine
LOE Approaching
Eisai
ORAL · CAPSULE
1990
NDA30/100
HIBICLENS
chlorhexidine gluconate
LOE Approaching
TOPICAL · SOLUTION
1976
NDA30/100
HIBICLENS
chlorhexidine gluconate
LOE Approaching
TOPICAL · SPONGE
1981
NDA30/100
HIBISTAT
chlorhexidine gluconate
LOE Approaching
TOPICAL · SOLUTION
1980
NDA30/100
HICON
sodium iodide i 131
LOE Approaching
Jubilant Therapeutics
ORAL · SOLUTION
hyperthyroidismselected cases of carcinoma of the thyroid
2003
NDA30/100
HIPPURAN I 131
iodohippurate sodium i-131
LOE Approaching
INJECTION · INJECTABLE
1968
NDA30/100
HIPPUTOPE
iodohippurate sodium i-131
LOE Approaching
Bracco
INJECTION · INJECTABLE
1970
NDA30/100
HIPREX
methenamine hippurate
LOE Approaching
ORAL · TABLET
1976
NDA30/100
HISTAMINE PHOSPHATE
histamine phosphate
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
1939
NDA30/100
HIVID
zalcitabine
LOE Approaching
Roche
ORAL · TABLET
1992
NDA30/100
HIWOLFIA
rauwolfia serpentina root
LOE Approaching
ORAL · TABLET
1954
NDA30/100
HMS
medrysone
LOE Approaching
AbbVie
OPHTHALMIC · SUSPENSION
1969
NDA30/100
HUMORSOL
demecarium bromide
LOE Approaching
Merck & Co.
OPHTHALMIC · SOLUTION/DROPS
1959
NDA30/100
HYCAMTIN
topotecan hydrochloride
LOE Approaching
Novartis
INJECTION · INJECTABLE
after initialsubsequent chemotherapy+3
1996
NDA30/100
HYCAMTIN
topotecan
LOE Approaching
Novartis
ORAL · CAPSULE
lung cancer
2007
NDA30/100
HYCODAN
hydrocodone bitartrate and homatropine methylbromide
LOE Approaching
ORAL · SYRUP
1943
NDA30/100
HYCOFENIX
guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride
Peak
Molecular Devices
ORAL · SOLUTION
2015
NDA30/100
HYDELTRA-TBA
prednisolone tebutate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1956
NDA30/100
HYDERGINE
ergoloid mesylates
LOE Approaching
Novartis
ORAL · SOLUTION
1981
NDA30/100
HYDERGINE
ergoloid mesylates
LOE Approaching
Novartis
SUBLINGUAL · TABLET
1953
NDA30/100
HYDERGINE
ergoloid mesylates
LOE Approaching
Novartis
ORAL · TABLET
1977
NDA30/100
HYDERGINE LC
ergoloid mesylates
LOE Approaching
Novartis
ORAL · CAPSULE
1983
NDA30/100
HYDREA
hydroxyurea
LOE Approaching
Viatris (2)
ORAL · CAPSULE
frequency of painful crisesto reduce the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises
1967
NDA30/100
HYDROCORTISONE
hydrocortisone
LOE Approaching
ORAL · TABLET
1955
NDA30/100